Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Notes Payables (2018 - 2022)

Inspire Medical Systems' Notes Payables history spans 3 years, with the latest figure at $12.2 million for Q2 2022.

  • On a quarterly basis, Notes Payables rose 299.93% to $12.2 million in Q2 2022 year-over-year; TTM through Jun 2022 was $12.2 million, a 299.93% increase, with the full-year FY2021 number at $9.2 million, changed N/A from a year prior.
  • Notes Payables hit $12.2 million in Q2 2022 for Inspire Medical Systems, roughly flat from $12.2 million in the prior quarter.
  • Over the last five years, Notes Payables for INSP hit a ceiling of $12.2 million in Q1 2022 and a floor of $681000.0 in Q1 2018.
  • Historically, Notes Payables has averaged $6.6 million across 3 years, with a median of $6.1 million in 2021.
  • The widest YoY moves for Notes Payables: up 299.93% in 2022, down 299.93% in 2022.
  • Tracing INSP's Notes Payables over 3 years: stood at $2.7 million in 2018, then soared by 237.55% to $9.2 million in 2021, then skyrocketed by 33.33% to $12.2 million in 2022.
  • Business Quant data shows Notes Payables for INSP at $12.2 million in Q2 2022, $12.2 million in Q1 2022, and $9.2 million in Q4 2021.